Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Chris Von Jako
AddedFeb 15, 2024
UpdatedMay 31, 2026
Chris Von Jako

Chris Von Jako

CEO, Polarean

CrunchbaseLinkedInThe Org

Chris Von Jako's Career

Polarean
Polarean

Durham, NC, US

CEO· C-Suite · Management
nView medical
nView medical

Salt Lake City, UT, US

Board Member· Board
NinePoint Medical
NinePoint Medical

Bedford, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Chris Von Jako's Career

Polarean
Polarean
Public$1.9M282011Durham, NC, US
CEO· C-Suite · Management

Leadership at Polarean

Frank SchulkesFrank SchulkesBoard Member
Kenneth WestKenneth WestBoard Member
Bastiaan DriehuysBastiaan DriehuysBoard Member
Chuck OsborneChuck OsborneBoard Member
nView medical
nView medical
Seed$3.3M172012Salt Lake City, UT, US
Board Member· Board

Leadership at nView medical

Lu ZhangLu ZhangBoard Member
Cristian AtriaCristian AtriaFounder

Similar to nView medical

New View SurgicalNew View SurgicalBoston, MA, USSurgical Devicesest. 2009New View SurgicalBoston, MA, US · est. 2009

New View Surgical: Innovating MIS with novel surgical imaging and access systems.

Series B · $28.1M35
MedivisMedivisNew York City, NY, USMedical Softwareest. 2016MedivisNew York City, NY, US · est. 2016

NYC-based Medivis uses AI and augmented reality to enhance medical imaging and surgical navigation.

Series A · $25M25
True Digital SurgeryTrue Digital SurgeryGoleta, CA, USMedical Imagingest. 2018True Digital SurgeryGoleta, CA, US · est. 2018

True Digital Surgery offers a 3D medical imaging platform for enhanced surgical procedure visualization.

Series B · $31M125
nSight SurgicalnSight SurgicalSan Francisco, CA, USSurgical Analyticsest. 2020nSight SurgicalSan Francisco, CA, US · est. 2020

Machine learning platform enhancing patient safety, particularly in surgery.

Seed · $4.3M20
NinePoint Medical
NinePoint Medical
Acquired$112.7M02008Bedford, MA, US
Board Member· Board

Leadership at NinePoint Medical

Chuck CarignanChuck CarignanFounder
Eric SwansonEric SwansonBoard Member
Eman NamatiEman NamatiCEO
Russell HirschRussell HirschBoard Member
Mark LevinMark LevinBoard Member
Thomas J Miller JrThomas J Miller JrBoard Member

Chris Von Jako's Similar Executives & Operators

Willix HalimWillix HalimCEO · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to Chris Von Jako

Jacques EssingerJacques EssingerBoard Member · PolaresKunal GuptaKunal GuptaCo-Founder · NovaLeslie CanaveraLeslie CanaveraCo-Founder · PolArcticBorui WangBorui WangCo-Founder · PolarrMike SpeetzenMike SpeetzenBoard Member · Polaris